This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Research Triangle Institute, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2017.
Company Filing History:
1 out of 359 
1 out of 3,690 
Years Active: 2017
Title: Kevin M Page: Innovator in Neurotransmitter Modulation
Introduction
Kevin M Page is a notable inventor based in Willow Spring, NC (US). He has made significant contributions to the field of pharmacology, particularly in the development of compounds that influence monoamine neurotransmitter levels. His work has implications for treating various conditions, including obesity and depression.
Latest Patents
Kevin M Page holds a patent for "Phenylmorpholines and analogues thereof." This patent encompasses compounds and prodrugs that function as releasers and/or uptake inhibitors of monoamine neurotransmitters such as dopamine, serotonin, and norepinephrine. The patent also details pharmaceutical compositions that may include additional therapeutic agents, along with methods for treating conditions responsive to neurotransmitter level modifications.
Career Highlights
Throughout his career, Kevin has worked with esteemed organizations such as the Research Triangle Institute and the National Institutes of Health, a component of the US Department of Health & Human Services. His experience in these institutions has allowed him to contribute to significant advancements in medical research and drug development.
Collaborations
Kevin has collaborated with notable professionals in his field, including Bruce Edward Blough and Richard B Rothman. These collaborations have further enriched his research and innovation efforts.
Conclusion
Kevin M Page's work in neurotransmitter modulation showcases his dedication to advancing medical science. His patent and career achievements reflect his significant impact on the field of pharmacology.